Use of Androgenic Anabolic Steroids linked to Increased Mortality Rates: JAMA
A recent investigation published in the recent edition of Journal of American Medical Association explored the perilous consequences of androgenic anabolic steroid (AAS) use by uncovering stark findings regarding mortality rates. The study examined the mortality and causes of death among a substantial cohort of AAS users by comparing them with a control group from the general population.
This study by the team of Josefine Windfeld-Mathiasen analyzed the records of Danish males who received a two-year doping sanction, inclusive of sports exclusion, due to the usage of AAS. This research which spanned from 2006 to 2018 identified individuals through sporadic inspections and drug testing conducted in fitness centers across Denmark. This cohort encompassed both occasional and dedicated gym-goers which reflected a broad spectrum of AAS users.
The findings of the study revealed a significant increase in mortality rates among AAS users when compared to the control group. Over the course of the study, 33 AAS users met untimely deaths, while 578 fatalities were observed in the control group. This discrepancy translated to a hazard ratio of 2.81 that indicates a substantially increased risk of mortality among AAS users.
Also, the causes of death among AAS users were deeply concerning, with the fatalities attributing to both natural and unnatural causes. The most prevalent natural causes included cancer and cardiovascular disease that underlined the severe health implications associated with AAS use. Unnatural deaths, primarily stemming from accidents were equally troubling which further emphasized the grave risks posed by these substances. While this study unveils invaluable light on the detrimental effects of AAS use, it also acknowledges the limitations including its observational nature and the absence of adjustments for potential confounding variables.
Source:
Windfeld-Mathiasen, J., Heerfordt, I. M., Dalhoff, K. P., Andersen, J. T., & Horwitz, H. (2024). Mortality Among Users of Anabolic Steroids. In JAMA. American Medical Association (AMA). https://doi.org/10.1001/jama.2024.3180
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.